Institute of Dentistry, University of Helsinki, Helsinki, Finland.
Liver Transpl. 2013 Feb;19(2):155-63. doi: 10.1002/lt.23573.
Recipients of liver transplantation (LT) receive lifelong immunosuppression, which causes side effects. We investigated self-reported oral symptoms and associated risk factors with the following hypothesis: symptoms and signs would differ between LT recipients of different etiology groups and also between LT recipients and a control population. Eighty-four LT recipients (64 with chronic liver disease and 20 with acute liver disease) were recruited for clinical oral and salivary examinations (median follow-up = 5.7 years). A structured questionnaire was used to record subjective oral symptoms. Matched controls (n = 252) came from the National Finnish Health 2000 survey. The prevalence of symptoms was compared between the groups, and the risk factors for oral symptoms were analyzed. Xerostomia was prevalent in 48.4% of the chronic LT recipients and in 42.1% of the acute LT recipients. This subjective feeling of dry mouth was only partly linked to objectively measured hyposalivation. The chronic transplant recipients had significantly lower unstimulated salivary flow rates than the acute transplant recipients (0.34 ± 0.31 versus 0.61 ± 0.49 mL/minute, P = 0.005). Among the chronic transplant recipients, hyposalivation with unstimulated salivary flow was associated with fewer teeth (17.7 ± 8.2 versus 21.9 ± 8.4, P = 0.047) and more dentures (33.3% versus 12.2%, P = not significant). The chronic patients reported significantly more dysphagia than their controls (23.4% versus 11.5%, P = 0.02). Increases in the number of medications increased the symptoms in all groups. In conclusion, dysphagia was significantly more prevalent among the chronic LT recipients versus the controls. The number of medications was a risk factor for dry mouth-related symptoms for both the LT recipients and the controls. The chronic transplant recipients presented with lower salivary flow rates than the acute transplant recipients. Hyposalivation correlated with generally worse oral health among the chronic transplant recipients. These differences between the chronic and acute LT recipients may have been due to differences in their medical conditions due to the different etiologies.
肝移植(LT)受者需终身接受免疫抑制治疗,这会带来副作用。我们开展了此项研究,旨在调查自述口腔症状及相关危险因素。我们提出如下假说:不同病因组的 LT 受者之间以及 LT 受者与对照组之间,症状和体征可能存在差异。我们共招募了 84 例 LT 受者(64 例慢性肝病,20 例急性肝病)进行临床口腔和唾液检查(中位随访时间=5.7 年)。采用结构化问卷记录主观口腔症状。选择 252 例匹配对照来自全国芬兰健康 2000 调查。比较各组间症状的发生率,并分析口腔症状的危险因素。慢性 LT 受者中口干症的患病率为 48.4%,急性 LT 受者中为 42.1%。这种主观的口干感仅部分与客观测量的唾液流率降低有关。慢性移植受者的未刺激唾液流率显著低于急性移植受者(0.34±0.31 比 0.61±0.49 毫升/分钟,P=0.005)。在慢性移植受者中,未刺激唾液流率降低与牙齿数量减少(17.7±8.2 比 21.9±8.4,P=0.047)和更多义齿(33.3%比 12.2%,P=无显著差异)相关。慢性患者报告的吞咽困难明显多于对照组(23.4%比 11.5%,P=0.02)。所有组中,药物种类增加与症状增加相关。总之,与对照组相比,慢性 LT 受者的吞咽困难更为常见。药物种类增加是 LT 受者和对照组口干相关症状的危险因素。慢性移植受者的唾液流率低于急性移植受者。慢性移植受者的唾液流率降低与口腔健康总体较差相关。慢性和急性 LT 受者之间的这些差异可能是由于不同病因导致的疾病状况不同所致。